Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner xarelto and high blood pressure (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use – and failure to perform so might be grounds for compensation. Our lawyers are operating difficult to have these hurt by the drug the compensation they are entitled to.
While bleeding is really a frequent complication connected with anticoagulants, it has been alleged that Xarelto is much more harmful than traditional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, inside the event of an emergency, sufferers may possibly be at danger for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.
Should you or even a loved one suffered a significant bleeding occasion right after taking Xarelto, you might have legal recourse. For a lot more data, speak to us nowadays to have your case reviewed, cost-free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. Additionally, they’re searching for punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.